Search results
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 12 hours agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...
Why Mama Cass' Daughter Owen Was Not Part of Wilson Phillips: 'My Voice Was Too Loud' (Exclusive)
People via Yahoo News· 6 hours agoOn" and "Release Me." Looking back, Elliot-Kugell tells PEOPLE that her lack of involvement in the...
U.S. Drug Control Agency Moves to Reclassify Marijuana in a Historic Shift That Would Benefit Auri...
NewMediaWire via Yahoo Finance· 17 hours agoDALLAS, TX - (NewMediaWire) - May 06, 2024 - Auri Inc. (OTCPK: AURI) (the Company): Today, the ...
As ‘Bob Hearts Abishola’ Ends, Cocreator Calls Out ‘Performative’ TV Trend to Create Then Abandon...
The Wrap via Yahoo News· 5 hours ago“It always happens that way,” Gina Yashere tells TheWrap, while adding that its inclusive legacy...
Bernie Sanders, 82, Will Seek Another 6-Year Senate Term, Calling His Service 'the Honor of My Life'
People via Yahoo News· 11 hours agoSanders, a third-term senator who previously served eight terms in the House of Representatives,...
Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug
Proactive Investors· 7 days ago“We've written many times how the major reason current multiples are depressed is lack of institutional ownership, this due to a combination of major exchanges ...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC)as...
FOX 23 News Albany· 6 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday
Motley Fool via Yahoo Finance· 6 days agoBut perhaps the most onerous headwind that will be reversed by rescheduling is...companies will no...
Travere Therapeutics Reports Q1 2024 Results: A Mixed Financial Performance Amidst Strategic ...
GuruFocus.com via Yahoo Finance· 8 hours agoDespite this, the company highlighted substantial progress in its drug development and regulatory milestones. Company Overview Travere ...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 4 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...